Dr. Elizabeth Reed Aden, a PHD and a former pharma industry executive and the author of The Goldilock Genome joins eHealth Radio and the Health News and Pharmaceutical Channels.
Listen to interview with host Eric…
Genome Medical is making genetics care accessible and actionable for patients through seven-day-a-week access to genetic services. By partnering with health systems, molecular testing laboratories and life sciences organizations, Genome Medical is expanding the…
Continue Reading
What You Should Know:
– Genomics plc, a leader in polygenic risk score (PRS) technology, and pharmaceutical giant GSK inks a new collaboration to explore the potential of PRS for optimizing clinical trial design.
– The…
Continue Reading
Karen Grinzaid, Assistant Professor of Human Genetics and Executive Director of JScreen, a national online genetic disease screening program based out of Emory University School of Medicine again joins eHealth Radio and the Health…
Continue Reading
The science of longevity and the pursuit of increasing healthy lifespan are at the forefront of medical and biological research, intertwining complex facets of genetics, nutrition, exercise, and technology. Longevity science seeks not just…
Continue Reading
What You Should Know:
– 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for 23ME-01473 (referred to…
Continue Reading
Sano Genetics has raised $11.4m in a new funding round to help power a revolution in precision medicine by deploying artificial intelligence to help streamline the clinical trial process.The Cambridge-based company is building a…
Continue Reading
What You Should Know:
– Invitae (NYSE: NVTA), a medical genetics company, announced the completion of its sale of certain reproductive health assets, including carrier screening and non-invasive prenatal screening (NIPS), to Natera (NASDAQ: NTRA).
–…
Continue Reading
What You Should Know:
– Sano Genetics, a software company that is revolutionizing precision medicine research, has secured $11.4M in new funding.
– This latest investment, led by Plural with participation from existing investors MMC Ventures,…
Continue Reading
Top News
Medical genetics company Invitae divests its Ciitizen patient-controlled health data business to that company’s leadership team and a group of investors who will operate it as an independent company. Terms were not disclosed….
Continue Reading
